From May 30 to June 3 in Chicago, Illinois, and online, cancer researchers and clinicians from around the world will gather for the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.

The Association for Clinical Oncology (ASCO) is outlining key priorities for the next generation of biomedical innovation policy in response to “A Roadmap for 21st Century Cures,” a white paper ...

The Association for Clinical Oncology (ASCO) is urging lawmakers to prioritize federal cancer research in Fiscal Year (FY) 2026 by providing the National Institutes of Health (NIH), National Cancer ...

On May 29, the American Society of Clinical Oncology (ASCO) issued a new position statement with recommendations to properly implement and regulate artificial intelligence (AI) in the prior ...

Disclaimer This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information ...

The nomination period for the upcoming ASCO Election is now closed. ASCO staff will review recommendations to confirm eligibility of submitted names. Following the eligibility check, the ASCO ...

In addition to gaining a global network of more than 50,000 peers, ASCO membership includes a range of benefits to enhance your career, practice, and research.

Disclaimer This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information ...

Who does this study affect? People with metastatic castration-sensitive prostate cancer (mCSPC) with alterations in the homologous recombination repair (HRR) genes What did this study find?* The phase ...

“This trial emphasizes the importance of germline and somatic testing in patients with metastatic prostate cancer at the time of diagnosis; homologous recombination repair mutations have been ...